N. Watanabe et al., ENDOGENOUS TUMOR-NECROSIS-FACTOR INHIBITS THE CYTOTOXICITY OF EXOGENOUS TUMOR-NECROSIS-FACTOR AND ADRIAMYCIN IN PANCREATIC-CARCINOMA CELLS, Pancreas, 13(4), 1996, pp. 395-400
Pancreatic carcinoma is one of the most devastating neoplasms with reg
ard to its resistance to conventional therapy. In a previous report, w
e found that endogenous tumor necrosis factor (enTNF) exerts an intrac
ellular protective effect against exogenous TNF- and Adriamycin (ADM)-
induced cytotoxicity by scavenging oxygen free radicals (OFR) with ind
uced manganous superoxide dismutase (MnSOD). We also know that glutath
ione S-transferase pi (GST-pi) and glutathione (GSH) also scavenge OFR
. It remains unclear to what extent enTNF and MnSOD induced by enTNF r
egulate the sensitivity to ADM and exogenous TNF among different carci
noma cells. In this study, we examined the relationship between ADM an
d exogenous TNF sensitivity and enTNF expression and MnSOD activity in
four pancreatic carcinoma lines. We determined whether ADM and exogen
ous TNF sensitivity could be predicted by measuring enTNF expression a
nd MnSOD activity in the carcinoma cells. The sensitivity to TNF and A
DM varied with the cell lines, and TNF sensitivity correlated well wit
h Adriamycin sensitivity. Moreover, enTNF expression and MnSOD activit
y correlated positively with resistance to ADM and exogenous TNF. When
MIAPaCa-2 cells, which had the lowest enTNF expression and the highes
t sensitivity to exogenous TNF and ADM, were transfected with the nons
ecretory-type human TNF gene (pTNF Delta pro) to increase enTNF synthe
sis, their intracellular MnSOD activity and exogenous TNF and ADM resi
stance were increased. These findings suggest that MnSOD plays a criti
cal role in scavenging OFR induced by ADM and exogenous TNF. enTNF is
the most important factor that regulates the production of MnSOD. Ther
efore, it is plausible that inhibition of enTNF expression or MnSOD ac
tivity in pancreatic carcinoma would improve the efficacy of therapies
for pancreatic carcinoma.